CN108265021B - Leech cell in-vitro culture medium and culture method thereof - Google Patents
Leech cell in-vitro culture medium and culture method thereof Download PDFInfo
- Publication number
- CN108265021B CN108265021B CN201810268999.6A CN201810268999A CN108265021B CN 108265021 B CN108265021 B CN 108265021B CN 201810268999 A CN201810268999 A CN 201810268999A CN 108265021 B CN108265021 B CN 108265021B
- Authority
- CN
- China
- Prior art keywords
- culture
- leech
- tissue
- insect
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000545744 Hirudinea Species 0.000 title claims abstract description 71
- 239000001963 growth medium Substances 0.000 title claims abstract description 23
- 238000000338 in vitro Methods 0.000 title claims abstract description 17
- 238000012136 culture method Methods 0.000 title claims abstract description 8
- 210000004027 cell Anatomy 0.000 claims abstract description 126
- 241000238631 Hexapoda Species 0.000 claims abstract description 49
- 239000006143 cell culture medium Substances 0.000 claims abstract description 45
- 230000029087 digestion Effects 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 19
- 210000001082 somatic cell Anatomy 0.000 claims abstract description 16
- 238000004113 cell culture Methods 0.000 claims abstract description 10
- 102000004142 Trypsin Human genes 0.000 claims abstract description 6
- 108090000631 Trypsin Proteins 0.000 claims abstract description 6
- 239000012588 trypsin Substances 0.000 claims abstract description 6
- 238000011084 recovery Methods 0.000 claims abstract description 4
- 238000000926 separation method Methods 0.000 claims abstract description 3
- 210000001519 tissue Anatomy 0.000 claims description 106
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 72
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims description 36
- 229930182555 Penicillin Natural products 0.000 claims description 36
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 36
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims description 36
- 229960003942 amphotericin b Drugs 0.000 claims description 36
- 229940049954 penicillin Drugs 0.000 claims description 36
- 239000000243 solution Substances 0.000 claims description 36
- 229960005322 streptomycin Drugs 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- 238000002791 soaking Methods 0.000 claims description 26
- 238000012258 culturing Methods 0.000 claims description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 14
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 14
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 14
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 14
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 14
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 14
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 14
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 14
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims description 14
- MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical compound OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 14
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 14
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 239000012153 distilled water Substances 0.000 claims description 12
- 210000002615 epidermis Anatomy 0.000 claims description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 9
- 229940024606 amino acid Drugs 0.000 claims description 9
- 235000001014 amino acid Nutrition 0.000 claims description 9
- 150000001413 amino acids Chemical class 0.000 claims description 9
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 8
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 8
- QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 claims description 7
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 7
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 claims description 7
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 claims description 7
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 7
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 7
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 7
- 239000011665 D-biotin Substances 0.000 claims description 7
- 235000000638 D-biotin Nutrition 0.000 claims description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 7
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 7
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 7
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 7
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 7
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 7
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 7
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 7
- 229930182844 L-isoleucine Natural products 0.000 claims description 7
- 239000004395 L-leucine Substances 0.000 claims description 7
- 235000019454 L-leucine Nutrition 0.000 claims description 7
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 7
- 229930195722 L-methionine Natural products 0.000 claims description 7
- 229930182821 L-proline Natural products 0.000 claims description 7
- -1 L-tyrosine disodium hydrogen phosphate Chemical compound 0.000 claims description 7
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 7
- 239000004473 Threonine Substances 0.000 claims description 7
- 229960003767 alanine Drugs 0.000 claims description 7
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 7
- 229960001230 asparagine Drugs 0.000 claims description 7
- 229960005261 aspartic acid Drugs 0.000 claims description 7
- 229940000635 beta-alanine Drugs 0.000 claims description 7
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 7
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 7
- 239000011666 cyanocobalamin Substances 0.000 claims description 7
- 210000002950 fibroblast Anatomy 0.000 claims description 7
- 229940014144 folate Drugs 0.000 claims description 7
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 7
- 235000019152 folic acid Nutrition 0.000 claims description 7
- 239000011724 folic acid Substances 0.000 claims description 7
- 239000001530 fumaric acid Substances 0.000 claims description 7
- 229960002989 glutamic acid Drugs 0.000 claims description 7
- 229960000310 isoleucine Drugs 0.000 claims description 7
- 229960003136 leucine Drugs 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 229960004452 methionine Drugs 0.000 claims description 7
- 210000004877 mucosa Anatomy 0.000 claims description 7
- 229960002429 proline Drugs 0.000 claims description 7
- PFIPZKASKUWLHH-UHFFFAOYSA-N pyridoxamine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CN)=C1O PFIPZKASKUWLHH-UHFFFAOYSA-N 0.000 claims description 7
- 229960002477 riboflavin Drugs 0.000 claims description 7
- 235000019192 riboflavin Nutrition 0.000 claims description 7
- 239000002151 riboflavin Substances 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000001384 succinic acid Substances 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 235000019157 thiamine Nutrition 0.000 claims description 7
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 7
- 229960003495 thiamine Drugs 0.000 claims description 7
- 239000011721 thiamine Substances 0.000 claims description 7
- 229960002898 threonine Drugs 0.000 claims description 7
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 210000003771 C cell Anatomy 0.000 claims description 6
- 238000007667 floating Methods 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 210000003079 salivary gland Anatomy 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
- 239000012091 fetal bovine serum Substances 0.000 claims 2
- 239000002504 physiological saline solution Substances 0.000 claims 2
- 241000143437 Aciculosporium take Species 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 235000019766 L-Lysine Nutrition 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 claims 1
- 229940054666 biotin 0.15 mg Drugs 0.000 claims 1
- 229960002104 cyanocobalamin Drugs 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229940104273 niacin 0.15 mg Drugs 0.000 claims 1
- 229960005190 phenylalanine Drugs 0.000 claims 1
- 238000003672 processing method Methods 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 229960004295 valine Drugs 0.000 claims 1
- 239000008055 phosphate buffer solution Substances 0.000 description 39
- 239000003242 anti bacterial agent Substances 0.000 description 23
- 229940088710 antibiotic agent Drugs 0.000 description 22
- 238000005406 washing Methods 0.000 description 21
- 239000007853 buffer solution Substances 0.000 description 15
- 230000001079 digestive effect Effects 0.000 description 15
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 15
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 12
- 239000011259 mixed solution Substances 0.000 description 10
- 238000010008 shearing Methods 0.000 description 10
- 102000007625 Hirudins Human genes 0.000 description 9
- 108010007267 Hirudins Proteins 0.000 description 9
- 229940006607 hirudin Drugs 0.000 description 9
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 9
- 238000010009 beating Methods 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000012894 fetal calf serum Substances 0.000 description 7
- FUOUNKGLDGJSME-JIZZDEOASA-N (2r)-2-amino-3-sulfanylpropanoic acid;dihydrochloride Chemical compound Cl.Cl.SC[C@H](N)C(O)=O FUOUNKGLDGJSME-JIZZDEOASA-N 0.000 description 6
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 6
- 239000007836 KH2PO4 Substances 0.000 description 6
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 6
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 6
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 6
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 6
- 229940116298 l- malic acid Drugs 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000011090 malic acid Nutrition 0.000 description 6
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 235000001968 nicotinic acid Nutrition 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 6
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 6
- 241000237903 Hirudo Species 0.000 description 5
- 108010019160 Pancreatin Proteins 0.000 description 5
- 238000007664 blowing Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 229940055695 pancreatin Drugs 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 238000004115 adherent culture Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 230000006266 hibernation Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000243818 Annelida Species 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 241000237678 Hirudinidae Species 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000258623 Whitmania pigra Species 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 241001233061 earthworms Species 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 239000010813 municipal solid waste Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0601—Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/16—Magnesium; Mg chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a leech cell in-vitro culture medium and a culture method thereof, wherein a leech tissue block after being cut into pieces is inoculated into a cell closed culture bottle, an Insect-cell culture medium is added, the culture is kept still in a cell culture box, then the separation culture is carried out by matching with a tissue block recovery method, and finally, purified leech somatic cells are obtained by a trypsin digestion method for further culture. Compared with other insect cell culture media, the method can more quickly and successfully obtain leech purified somatic cells, prepare for further carrying out leech cell in-vitro subculture, and build a set of in-vitro primary culture leech cell system.
Description
Technical Field
The invention relates to a leech in-vitro culture method, and belongs to the field of bioengineering.
Background
With the rapid development of life science, cell culture is an indispensable process for the whole biological engineering technology or one of the biological cloning technologies, and the development of the fields of cell biology, molecular biology, biochemistry and the like is promoted.
Leeches (Whitmania pigra Whitman) belong to the family of leeches of the class Hirudinidae of the phylum Annelida, and according to statistics, more than 600 species of leeches are distributed in the world, and nearly 100 species are distributed in China. Leeches belong to animals in the cold blood link, can grow and breed in south and north China, and mainly live in reservoirs, ditches, paddy fields and lakes and marshes in fresh water, and are most in ponds rich in organic matters or small rivers free of pollution. The optimum growth temperature is 10-40 deg.C, when the temperature is lower than 3 deg.C in northern area, the soil enters into hibernation period, and the hibernation activity is about more than 8 deg.C in 3-4 months of the next year. Leeches are omnivorous animals, which take blood or body fluid of animals as a main life style, plankton, insects and mollusks in water are usually used as main baits, and various animal internal organs, cooked egg yolks, compound feed, plant residues, freshwater snail, trash fish, earthworms and the like are used as baits under artificial conditions.
Researches show that the leech salivary gland secretion contains various bioactive substances such as hirudin and the like and has wide application prospect in medicine. Hirudin, leech hyaluronidase, antipixin, anesthetic, vasodilator, prostaglandin and the like, has the effects of reducing blood fat, protecting heart and cerebral vessels, resisting blood coagulation, resisting tumors and the like, and has important research significance. Therefore, there is a great clinical need for natural hirudin. The existing hirudin extraction mainly adopts biological engineering means to recombine and stimulate leech salivary gland to secrete hirudin, and the two methods have high cost and extremely low yield of the obtained hirudin. With the development of cell in vitro culture technology, obtaining hirudin by culturing leech cells in vitro becomes a popular research subject, and researches show that the hirudin obtained by the method not only has high yield, but also has the effect which is comparable to the hirudin obtained by stimulating salivary gland secretion of leech. However, the current leech cell in-vitro culture technology is still in the sprouting stage, and the selection of a culture medium, the determination of culture conditions, the selection of antibiotics and the like are all difficult problems which need to be overcome urgently.
Disclosure of Invention
Aiming at the problems, the invention provides a leech cell in-vitro culture method.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
the leech cell in-vitro culture medium is characterized by comprising the following components in parts by weight:
inorganic salts:
NaCl1420mg/L,ZnCL2 876.54mg/L,MgSO4·7H2O1743.48mg/L,KCl2080mg/L,KH2PO4·2H2O 1000mg/L;
amino acids:
9000mg/L of DL-serine, 620mg/L of glycine, 700mg/L of L-arginine hydrochloride, 400mg/L of L-asparagine, 350mg/L of L-aspartic acid, 160mg/L of L-cysteine dihydrochloride, 3500mg/L of L-glutamic acid, 2000mg/L of L-histidine hydrochloride, 200mg/L of L-isoleucine, 150mg/L of L-leucine, 850mg/L of L-lysine hydrochloride, 100mg/L of L-methionine, 100mg/L of L-phenylalanine, 500mg/L of L-proline, 200mg/L of L-threonine, 150mg/L of L-tryptophan, 580mg/L of disodium hydrogen phosphate L-tyrosine, l-valine 200mg/L, beta-alanine 400mg/L and L-alanine 225 mg/L;
vitamins:
0.15mg/L of D-biotin, 0.15mg/L of D-calcium pantothenate, 0.15mg/L of folate, 0.10mg/L of cyanocobalamine, 0.15mg/L of nicotinic acid, 0.15mg/L of pyridoxamine hydrochloride, 0.15mg/L of riboflavin, 0.10mg/L of thiamine and 0.15mg/L of p-aminobenzoic acid;
and (3) the other:
2000mg/L of sucrose, 1500mg/L of D-glucose, 500mg/L of D-fructose, 600mg/L of maltose, 330mg/L of alpha-ketoglutaric acid, 90mg/L of fumaric acid, 90mg/L of succinic acid and 90mg/L of L-malic acid; the pH was adjusted to 7.4 with 1.0N KOH.
A leech cell in vitro culture method comprises inoculating minced leech tissue blocks into a cell closed culture bottle, adding the Insect-cell culture medium, performing static culture in a cell culture box, performing separation culture by using a tissue block recovery method, and performing further culture on purified leech somatic cells obtained by a trypsin digestion method. The method comprises the following specific steps
1) Soaking living Hirudo in normal saline for 1 hr to remove impurities and ensure somatic cell activity to the maximum extent, cleaning surface mucosa with normal saline, washing with distilled water for three times, soaking in 70% ethanol for 5min to remove bacteria on body surface, and washing with distilled water repeatedly to remove ethanol;
2) transferring the leech subjected to the epidermis sterilization treatment in the step 1) into an ultraclean workbench, putting the leech into a sterile culture dish containing sterile PBS, and shearing two ends of a leech body by using sterile scissors and tweezers to take head tissues;
3) transferring the head tissue in the step 2) into another sterile culture dish filled with PBS buffer solution, and soaking the head tissue in the leech body; dissecting the head tissue with a sterile scalpel, taking the tissue in the middle of the epidermis, and washing with a sterile PBS buffer solution;
4) soaking the tissue in the step 3) in 75% alcohol for 1min, taking out, rinsing with sterile PBS buffer solution, and repeating for three times;
5) placing the tissue in the step 4) in a sterile culture dish containing sterile PBS, shearing the tissue into small tissue blocks by using sterile scissors and tweezers, and soaking for 5 min;
6) removing the tissue debris floating on the upper part of the fine tissue block in the step 5), sucking the tissue block paste by using a 5mL gun head, paving the sucked paste tissue at the bottom of a bottle, uniformly distributing the tissue block paste in a 25mL cell closed culture bottle, adding 5mL of an Insect-CCulture Insect cell culture medium, and standing and culturing for 60min in a 25 ℃ cell culture box for adherence.
7) Sucking the excess liquid at the bottom of the culture bottle after the static adherent culture for 60min in the step 6) by using a suction pipe, slowly adding 5mL of an Insect-cell culture medium into the bottle mouth by using a liquid-transferring gun, covering a tissue block, continuing primary culture, and timely replacing fresh culture solution when the color of the culture solution becomes dark; after primary culture for 6-12h, when the bottom of the bottle is about to be filled with cells, removing the tissue blocks, re-inoculating the removed tissue blocks into a new culture bottle, culturing in an incubator, and timely replacing fresh culture solution.
8) Discarding the culture solution of the cells obtained in the step 7), cleaning the cells by sterile PBS, adding 2mL of pancreatin digestive juice, digesting the cells for 50s, slightly shaking the culture bottle, observing the cells under a microscope, immediately adding 5mL of an institute-CCulture Insect cell culture medium to stop digestion when the fibroblasts shrink to become round and float and the leech somatic cells shrink but do not float, slightly shaking the cells to discard the culture solution, adding 4mL of PBS, slightly washing the residual fibroblasts, adding 2mL of digestive juice, digesting the cells for 3min, discarding 1mL of the digestive juice, beating the bottom of the bottle from the bottom to completely drop the cells, adding 5mL of a Lanselect-CCulture Insect cell culture medium to stop digestion, repeatedly blowing the cells to disperse cell clusters into single cells.
9) And (3) filtering the cells obtained from the cells obtained in the step (8) by using eight layers of gauze, and inoculating the filtered cells into a 25mL culture bottle containing 5mL of Insect-cell culture medium with the culture temperature of 25 ℃ for 3 days.
The culture medium of the Insect cell of the culture medium Insect-CCulture used by the invention has the following formula:
inorganic salts:
NaCl1420mg/L,ZnCL2 876.54mg/L,MgSO4·7H2O1743.48mg/L,KCl2080mg/L,KH2PO4·2H2O 1000mg/L;
amino acids:
9000mg/L of DL-serine, 620mg/L of glycine, 700mg/L of L-arginine hydrochloride, 400mg/L of L-asparagine, 350mg/L of L-aspartic acid, 160mg/L of L-cysteine dihydrochloride, 3500mg/L of L-glutamic acid, 2000mg/L of L-histidine hydrochloride, 200mg/L of L-isoleucine, 150mg/L of L-leucine, 850mg/L of L-lysine hydrochloride, 100mg/L of L-methionine, 100mg/L of L-phenylalanine, 500mg/L of L-proline, 200mg/L of L-threonine, 150mg/L of L-tryptophan, 580mg/L of disodium hydrogen phosphate L-tyrosine, l-valine 200mg/L, beta-alanine 400mg/L and L-alanine 225 mg/L;
vitamins:
0.15mg/L of D-biotin, 0.15mg/L of D-calcium pantothenate, 0.15mg/L of folate, 0.10mg/L of cyanocobalamine, 0.15mg/L of nicotinic acid, 0.15mg/L of pyridoxamine hydrochloride, 0.15mg/L of riboflavin, 0.10mg/L of thiamine and 0.15mg/L of p-aminobenzoic acid;
and (3) the other:
2000mg/L of sucrose, 1500mg/L of D-glucose, 500mg/L of D-fructose, 600mg/L of maltose, 330mg/L of alpha-ketoglutaric acid, 90mg/L of fumaric acid, 90mg/L of succinic acid and 90mg/L of L-malic acid;
the pH was adjusted to 7.4 with 1.0N KOH and 15% inactivated insect-specific special grade fetal calf serum was added before use.
The content of penicillin added into the sterile PBS buffer solution used in the invention is 600U/mL, the content of streptomycin is 600U/mL, and the content of amphotericin B is 15 mug/mL; the size of the tissue block after being cut into pieces is 1mm3。
The antibiotic-containing Insect cell culture medium used in the invention is additionally added with special grade fetal calf serum with penicillin content of 600U/mL, streptomycin content of 600U/mL, amphotericin B content of 15 mu g/mL and inactivated 15%.
The invention has the beneficial effects that: the invention provides a cell in-vitro culture method for primary culture of leech cells, and also provides an optimized insect cell culture medium, which is used for obtaining leech purified somatic cells more quickly and successfully compared with other insect cell culture media, preparing for further carrying out in-vitro subculture of leech cells and constructing a set of in-vitro primary culture leech cell system. The invention provides accurate and reliable experimental basis for the in vitro culture of the leech cells.
Detailed Description
The invention will be better understood from the following examples. However, those skilled in the art will readily appreciate that the specific material ratios, process conditions and results described in the examples are merely illustrative of the invention and should not be construed as limiting the invention.
The leeches used in the following examples were derived from: hirudo nipponica.
Example 1
The invention provides a leech living body growth cycle selection method which comprises the following specific steps
The method comprises the following steps: soaking 1, 2 and 3 years old living leeches in normal saline for 1h respectively, primarily removing impurities in vivo and ensuring the vitality of somatic cells to the maximum extent, cleaning surface mucosa with normal saline until the surface mucosa is clean, finally cleaning with distilled water for three times, soaking in 70% alcohol for 5min, removing body surface bacteria, and repeatedly washing with distilled water to remove alcohol;
step two: transferring the leeches respectively subjected to the epidermis sterilization treatment in the step one into an ultraclean workbench, putting the leeches into a sterile culture dish containing sterile PBS, and shearing two ends of leeches by using sterile scissors and tweezers to take head tissues;
step three: transferring the head tissue in the second step into another sterile culture dish filled with PBS buffer solution, and soaking the leech body;
step four: respectively dissecting the head tissues in the third step by using a sterile scalpel, taking the tissues in the middle of the epidermis, and washing by using a sterile PBS buffer solution;
step five: soaking the tissue in the fourth step in 75% alcohol for 1min, taking out, rinsing with sterile PBS buffer solution, and repeating for three times;
step six: placing the tissue in the fifth step into a sterile culture dish containing sterile PBS, shearing the tissue into small tissue blocks by using sterile scissors and tweezers, and soaking for 5 min;
step seven: removing the tissue debris floating on the upper part of the fine tissue block in the sixth step, respectively sucking the tissue block paste by using a 5mL gun head, paving the sucked paste tissue at the bottom of a bottle, uniformly distributing the tissue block paste in a 25mL cell closed culture bottle, adding 5mL Insect-cell culture medium containing antibiotics into the bottle, and standing and culturing for 60min in a 25 ℃ cell culture box.
Step eight: absorbing excess liquid at the bottom of the culture bottle after the culture bottle is subjected to static adherent culture for 60min by using a suction tube, slowly adding 5mL of Insect-cell culture medium containing antibiotics into the bottle mouth by using a liquid-transferring gun, covering a tissue block, and timely replacing fresh culture solution when the color of the culture solution becomes dark; after primary culture for 6-12h, when the bottom of the bottle is about to be filled with cells, removing the tissue blocks, re-inoculating the removed tissue blocks into a new culture bottle, culturing in an incubator, and timely replacing fresh culture solution.
Step nine: respectively removing culture solution from the cells obtained in the step eight, cleaning the cells by using sterile PBS, adding 2mL of pancreatin digestive juice, digesting for 50s, slightly shaking the culture bottle, observing under a microscope, immediately adding 5mL of an antibiotic-containing Insect cell culture medium to stop digestion when the leech somatic cells shrink but do not float, slightly shaking the culture bottle to remove the culture solution, adding 4mL of PBS, slightly washing residual fibroblasts, adding 2mL of digestive juice, digesting for 3min, removing 1mL of digestive juice, beating the bottom of the bottle from the bottom to completely drop the cells, adding 6mL of the antibiotic-containing Insect cell culture medium to stop digestion, and repeatedly blowing the cells to disperse cell clusters into single cells.
Step ten: and (4) filtering the cells obtained from the cell obtained in the ninth step by using eight layers of gauze, inoculating the filtered cells into a 25mL culture bottle containing 5mL of the Insect cell culture medium of the Insect-shaped cell, culturing at the temperature of 25 ℃ for 3 days, continuing transferring the cells into another 25mL culture bottle containing 5mL of the Insect-shaped cell culture medium of the Insect-shaped cell, and repeating the previous operation.
The culture medium of the Insect cell of the culture medium Insect-CCulture used by the invention has the following formula:
inorganic salts:
NaCl1420mg/L,ZnCL2 876.54mg/L,MgSO4·7H2O1743.48mg/L,
KCl2080mg/L,KH2PO4·2H2O 1000mg/L;
amino acids:
9000mg/L of DL-serine, 620mg/L of glycine, 700mg/L of L-arginine hydrochloride, 400mg/L of L-asparagine, 350mg/L of L-aspartic acid, 160mg/L of L-cysteine dihydrochloride, 3500mg/L of L-glutamic acid, 2000mg/L of L-histidine hydrochloride, 200mg/L of L-isoleucine, 150mg/L of L-leucine, 850mg/L of L-lysine hydrochloride, 100mg/L of L-methionine, 100mg/L of L-phenylalanine, 500mg/L of L-proline, 200mg/L of L-threonine, 150mg/L of L-tryptophan, 580mg/L of disodium hydrogen phosphate L-tyrosine, l-valine 200mg/L, beta-alanine 400mg/L and L-alanine 225 mg/L;
vitamins:
0.15mg/L of D-biotin, 0.15mg/L of D-calcium pantothenate, 0.15mg/L of folate, 0.10mg/L of cyanocobalamine, 0.15mg/L of nicotinic acid, 0.15mg/L of pyridoxamine hydrochloride, 0.15mg/L of riboflavin, 0.10mg/L of thiamine and 0.15mg/L of p-aminobenzoic acid;
and (3) the other:
2000mg/L of sucrose, 1500mg/L of D-glucose, 500mg/L of D-fructose, 600mg/L of maltose, 330mg/L of alpha-ketoglutaric acid, 90mg/L of fumaric acid, 90mg/L of succinic acid and 90mg/L of L-malic acid;
the pH was adjusted to 7.4 with 1.0N KOH and 15% inactivated insect-specific special grade fetal calf serum was added before use.
The content of penicillin added into the sterile PBS buffer solution used in the invention is 600U/mL, the content of streptomycin is 600U/mL, and the content of amphotericin B is 15 mug/mL; the size of the tissue block after being cut into pieces is 1mm3。
The antibiotic-containing Insect cell culture medium used in the invention is additionally added with special grade fetal calf serum with penicillin content of 600U/mL, streptomycin content of 600U/mL, amphotericin B content of 15 mu g/mL and inactivated 15%.
This example shows that selection of 2 year old samples resulted in free cells after 10h of primary culture and subsequent adherent growth of subcultured cells, and that 1, 3 year old samples showed no free cells after 15h of primary culture. The invention can be used as an accurate basis for selecting leech living bodies.
Example 2
The invention provides an insect cell culture medium optimized for leech cell primary culture, which comprises the following specific steps
The method comprises the following steps: soaking living Hirudo in normal saline for 1 hr to remove impurities and ensure somatic cell activity to the maximum extent, cleaning surface mucosa with normal saline, washing with distilled water for three times, soaking in 70% ethanol for 5min to remove bacteria on body surface, and washing with distilled water repeatedly to remove ethanol;
step two: transferring the leech subjected to the epidermis sterilization treatment in the step one into an ultraclean workbench, putting the leech into a sterile culture dish containing 600U/mL of PBS containing different antibiotics, and shearing two ends of a leech body by using sterile scissors and tweezers to take head tissues;
step three: transferring the head tissue in the second step into another sterile culture dish filled with PBS buffer solution, and soaking the leech body;
step four: dissecting the head tissue in the third step with a sterile scalpel, taking the tissue in the middle of the epidermis, and washing with a sterile PBS buffer solution;
step five: soaking the tissue in the fourth step in 75% alcohol for 1min, taking out, rinsing with PBS buffer solution containing 600U/mL different antibiotics, and repeating for three times;
step six: placing the tissue in the fifth step into a sterile culture dish containing 600U/mL PBS containing different antibiotics, shearing the tissue into small tissue blocks by using sterile scissors and tweezers, and soaking for 5 min;
step seven: removing the tissue debris floating on the upper part of the fine tissue block in the sixth step, sucking the tissue block paste by using a 5mL gun head, paving the sucked paste tissue at the bottom of a bottle, uniformly distributing the tissue block paste in a 25mL cell closed culture bottle, adding 5mL of an Insect-CCulture Insect cell culture medium containing 600U/mL of different antibiotics, and carrying out standing culture in a 25 ℃ cell culture box for 60 min.
Step eight: absorbing excess liquid at the bottom of the culture bottle after the culture bottle is subjected to static adherent culture for 60min by using a suction pipe, slowly adding 5mL of Insect-cell culture medium containing 600U/mL of different antibiotics, SFX-Instrument and MGM-450 into the bottle mouth by using a liquid-transferring gun, covering tissue blocks, and timely replacing fresh culture solution when the color of the culture solution becomes dark; after culturing for 6-12h, when the bottom of the bottle is about to be filled with cells, removing the tissue blocks, re-inoculating the removed tissue blocks into a new culture bottle, culturing in an incubator, timely replacing fresh culture solution, and observing the growth condition of the cells.
Step nine: removing the culture solution from the cells obtained in the step eight, washing the cells by sterile PBS, adding 2mL of pancreatin digestive juice, digesting the cells for 50s, slightly shaking the culture bottle, observing the cells under a microscope until the leech somatic cells shrink but do not float, immediately adding 5mL of Insect cell culture medium containing 600U/mL of different antibiotics for treating infection-CCulture, SFX-institute and MGM-450, respectively, stopping digestion, slightly shaking, discarding the culture solution, adding 4mL of PBS, slightly washing to remove residual fibroblasts, adding 2mL of digestive juice, digesting for 3min, discarding 1mL of digestive juice, beating the bottom of the flask from the bottom to completely drop the cells, adding 5mL of Insect-cell culture medium containing 600U/mL of different antibiotics, SFX-Instrument and MGM-450 respectively to stop digestion, and repeatedly blowing and beating the cells to disperse cell clusters into single cells.
Step ten: and (4) filtering the cells obtained from the cell obtained in the ninth step by using eight layers of gauze, inoculating the filtered cells into a 25mL culture bottle containing 5mL of the Insect cell culture medium of the Insect-shaped cell, culturing at the temperature of 25 ℃ for 3 days, continuing transferring the cells into another 25mL culture bottle containing 5mL of the Insect-shaped cell culture medium of the Insect-shaped cell, and repeating the previous operation.
The culture medium of the Insect cell of the culture medium Insect-CCulture used by the invention has the following formula:
inorganic salts:
NaCl1420mg/L,ZnCL2 876.54mg/L,MgSO4·7H2O1743.48mg/L,
KCl2080mg/L,KH2PO4·2H2O 1000mg/L;
amino acids:
9000mg/L of DL-serine, 620mg/L of glycine, 700mg/L of L-arginine hydrochloride, 400mg/L of L-asparagine, 350mg/L of L-aspartic acid, 160mg/L of L-cysteine dihydrochloride, 3500mg/L of L-glutamic acid, 2000mg/L of L-histidine hydrochloride, 200mg/L of L-isoleucine, 150mg/L of L-leucine, 850mg/L of L-lysine hydrochloride, 100mg/L of L-methionine, 100mg/L of L-phenylalanine, 500mg/L of L-proline, 200mg/L of L-threonine, 150mg/L of L-tryptophan, 580mg/L of disodium hydrogen phosphate L-tyrosine, l-valine 200mg/L, beta-alanine 400mg/L and L-alanine 225 mg/L;
vitamins:
0.15mg/L of D-biotin, 0.15mg/L of D-calcium pantothenate, 0.15mg/L of folate, 0.10mg/L of cyanocobalamine, 0.15mg/L of nicotinic acid, 0.15mg/L of pyridoxamine hydrochloride, 0.15mg/L of riboflavin, 0.10mg/L of thiamine and 0.15mg/L of p-aminobenzoic acid;
and (3) the other:
2000mg/L of sucrose, 1500mg/L of D-glucose, 500mg/L of D-fructose, 600mg/L of maltose, 330mg/L of alpha-ketoglutaric acid, 90mg/L of fumaric acid, 90mg/L of succinic acid and 90mg/L of L-malic acid;
the pH was adjusted to 7.4 with 1.0N KOH and 15% inactivated insect-specific special grade fetal calf serum was added before use.
This example shows that in the 11 th hour of the primary culture of the Insect cell culture medium of the institute-CCulture containing 600U/mL three-antibody mixed solution, a small amount of cells are liberated on the periphery of the tissue block, and the shape is circular and transparent; the culture medium has no pollution, the survival time of the cells is long, and the cells grow adherent to the walls in the subsequent subculture experiment; after the SFX-Insect cell culture medium is subjected to primary culture for 15h, observing that a culture solution is still clear under a microscope, and the cells have no growth signs temporarily; after 15h of primary culture of MGM-450 insect cell culture medium, the culture solution is observed to be light yellow and black spots appear in the culture solution under a microscope, no free cells appear around the tissues, and the cells show temporary growth. Therefore, the optimized and improved Insect cell culture medium of the invention can be used as a culture medium for culturing leech cells.
Example 3
The antibiotic type selection provided by the invention comprises the following specific steps
The method comprises the following steps: soaking living Hirudo in normal saline for 1 hr to remove impurities and ensure somatic cell activity to the maximum extent, cleaning surface mucosa with normal saline, washing with distilled water for three times, soaking in 70% ethanol for 5min to remove bacteria on body surface, and washing with distilled water repeatedly to remove ethanol;
step two: transferring the leech subjected to the epidermis sterilization treatment in the step one into an ultraclean workbench, putting the leech into a sterile culture dish containing different antibiotics (penicillin, streptomycin and amphotericin B) PBS, and shearing two ends of a leech body by using sterile scissors and tweezers to take head tissues;
step three: transferring the head tissue in the second step to another sterile culture dish filled with PBS buffer solution of different antibiotics (penicillin, streptomycin and amphotericin B) and soaking the head tissue in the leech body;
step four: dissecting the head tissue in the third step with a sterile scalpel, taking the tissue in the middle of the epidermis, and washing with PBS (phosphate buffer solution) containing different antibiotics (penicillin, streptomycin and amphotericin B);
step five: soaking the tissue in the fourth step in 75% alcohol for 1min, taking out, rinsing with three-antibody mixed solution (penicillin, streptomycin and amphotericin B) PBS buffer solution with different concentrations, and repeating for three times;
step six: placing the tissue in the fifth step into a sterile culture dish containing different antibiotics (penicillin, streptomycin and amphotericin B) PBS, shearing into small tissue blocks by using sterile scissors and forceps, and soaking for 5 min;
step seven: removing the tissue debris floating on the upper part of the fine tissue block in the sixth step, sucking the tissue block paste by using a 5mL gun head, paving the sucked paste tissue at the bottom of a bottle, uniformly distributing the tissue block paste in a 25mL cell closed culture bottle, adding 5mL of an Insect cell culture medium containing different types of antibiotics (penicillin, streptomycin and amphotericin B) and carrying out standing culture in a 25 ℃ cell culture box for 60 min.
Step eight: absorbing excess liquid at the bottom of the culture bottle after the culture for 60min by using a suction pipe, slowly adding 5mL of an Insect cell culture medium containing different types of antibiotics (penicillin, streptomycin and amphotericin B) into the bottle mouth by using a liquid-transferring gun, covering a tissue block, and timely replacing fresh culture solution when the color of the culture solution becomes dark; after primary culture for 6-12h, when the bottom of the bottle is about to be filled with cells, removing the tissue blocks, re-inoculating the removed tissue blocks into a new culture bottle, culturing in an incubator, and timely replacing fresh culture solution.
Step nine: discarding the culture solution of the cells obtained in the step eight, washing the cells with PBS containing different antibiotics (penicillin, streptomycin and amphotericin B), adding 2mL of pancreatin digestive juice, digesting the cells for 50s, slightly shaking the culture flask, observing under a microscope, immediately adding 5mL of an Insect cell culture medium containing different antibiotics (penicillin, streptomycin and amphotericin B) to terminate digestion when the leech somatic cells shrink but do not float, slightly shaking the cells to discard the culture solution, adding 4mL of PBS containing different antibiotics (penicillin, streptomycin and amphotericin B), slightly washing residual fibroblasts, adding 2mL of digestive juice, digesting the cells for 2-3.5min, discarding 1mL of digestive juice, beating the bottom of the flask to completely drop the cells, adding 5mL of an Insect cell culture medium containing different antibiotics (penicillin, streptomycin and amphotericin B) to terminate digestion, repeatedly blowing and beating the cells to disperse the cell clusters into single cells.
Step ten: and (4) filtering the cells obtained from the ninth step by using eight layers of gauze, inoculating the filtered cells into a 25mL culture bottle containing 5mL of the Insect cell culture medium of the Insect-shaped culture medium of the Insect with different types of antibiotics (penicillin, streptomycin and amphotericin B), culturing at the temperature of 25 ℃ for 3 days, continuing transferring the cells into another 25mL culture bottle containing 5mL of the Insect-shaped culture medium, and repeating the previous operation.
The culture medium of the Insect cell of the culture medium Insect-CCulture used by the invention has the following formula:
inorganic salts:
NaCl1420mg/L,ZnCL2 876.54mg/L,MgSO4·7H2O1743.48mg/L,
KCl2080mg/L,KH2PO4·2H2O 1000mg/L;
amino acids:
9000mg/L of DL-serine, 620mg/L of glycine, 700mg/L of L-arginine hydrochloride, 400mg/L of L-asparagine, 350mg/L of L-aspartic acid, 160mg/L of L-cysteine dihydrochloride, 3500mg/L of L-glutamic acid, 2000mg/L of L-histidine hydrochloride, 200mg/L of L-isoleucine, 150mg/L of L-leucine, 850mg/L of L-lysine hydrochloride, 100mg/L of L-methionine, 100mg/L of L-phenylalanine, 500mg/L of L-proline, 200mg/L of L-threonine, 150mg/L of L-tryptophan, 580mg/L of disodium hydrogen phosphate L-tyrosine, l-valine 200mg/L, beta-alanine 400mg/L and L-alanine 225 mg/L;
vitamins:
0.15mg/L of D-biotin, 0.15mg/L of D-calcium pantothenate, 0.15mg/L of folate, 0.10mg/L of cyanocobalamine, 0.15mg/L of nicotinic acid, 0.15mg/L of pyridoxamine hydrochloride, 0.15mg/L of riboflavin, 0.10mg/L of thiamine and 0.15mg/L of p-aminobenzoic acid;
and (3) the other:
2000mg/L of sucrose, 1500mg/L of D-glucose, 500mg/L of D-fructose, 600mg/L of maltose, 330mg/L of alpha-ketoglutaric acid, 90mg/L of fumaric acid, 90mg/L of succinic acid and 90mg/L of L-malic acid;
the pH was adjusted to 7.4 with 1.0N KOH and 15% inactivated insect-specific special grade fetal calf serum was added before use.
The example shows that when the concentration of the antibiotic in the same type of culture medium is 600U/mL, only under the condition that penicillin, streptomycin and amphotericin B exist at the same time, cells around the tissue grow and free cells appear during primary culture, the culture solution is pollution-free, and a large amount of cells adhere to the wall in subculture, so that the growth condition is good; contamination occurs with penicillin, streptomycin and amphotericin B alone or in combination.
Example 4 selection of antibiotic concentrations provided by the invention comprises the following specific steps
The method comprises the following steps: soaking living Hirudo in normal saline for 1 hr to remove impurities and ensure somatic cell activity to the maximum extent, cleaning surface mucosa with normal saline, washing with distilled water for three times, soaking in 70% ethanol for 5min to remove bacteria on body surface, and washing with distilled water repeatedly to remove ethanol;
step two: transferring the leech subjected to the epidermis sterilization treatment in the step one into an ultraclean workbench, putting the leech into a sterile culture dish containing PBS (penicillin, streptomycin and amphotericin B) mixed liquor with different concentrations, and shearing off two ends of a leech body by using sterile scissors and tweezers to take head tissues;
step three: transferring the head tissue in the second step to another sterile culture dish filled with PBS buffer solution of three antibodies (penicillin, streptomycin and amphotericin B) with different concentrations, and soaking the head tissue in the leech body;
step four: dissecting the head tissue in the third step with a sterile scalpel, taking the tissue in the middle of the epidermis, and washing with PBS (phosphate buffer solution) of three-antibody mixed liquor (penicillin, streptomycin and amphotericin B) with different concentrations;
step five: soaking the tissue in the fourth step in 75% alcohol for 1min, taking out, rinsing with three-antibody mixed solution (penicillin, streptomycin and amphotericin B) PBS buffer solution with different concentrations, and repeating for three times;
step six: placing the tissue in the fifth step into a sterile culture dish containing PBS (mixed solution of three antibiotics with different concentrations) (penicillin, streptomycin and amphotericin B), shearing into small tissue blocks by using sterile scissors and tweezers, and soaking for 5 min;
step seven: removing the tissue debris floating on the upper part of the fine tissue block in the sixth step, sucking the tissue block paste by using a 5mL gun head, paving the sucked paste tissue at the bottom of a bottle, uniformly distributing the tissue block paste in a 25mL cell closed culture bottle, adding 5mL of three-antibody mixed solution (penicillin, streptomycin and amphotericin B) with different concentrations into an Insect cell culture medium with different concentrations, and carrying out standing culture in a 25 ℃ cell culture box for 60 min.
Step eight: absorbing excess liquid at the bottom of the culture bottle after the culture for 60min by using a suction pipe, slowly adding 5mL of an Insect cell culture medium containing three-antibody mixed liquid (penicillin, streptomycin and amphotericin B) with different concentrations into the bottle mouth by using a liquid-transferring gun, covering a tissue block, and timely replacing fresh culture solution when the color of the culture solution becomes dark; after primary culture for 6-12h, when the bottom of the bottle is about to be filled with cells, removing the tissue blocks, re-inoculating the removed tissue blocks into a new culture bottle, culturing in an incubator, and timely replacing fresh culture solution.
Step nine: removing the culture solution from the cells obtained in the step eight, washing by PBS (mixed solution of three antibodies with different concentrations (penicillin, streptomycin and amphotericin B)), adding 2mL of pancreatin digestive juice, digesting for 50s, slightly shaking the culture flask, observing under a microscope, immediately adding 5mL of the input-CCulture Insect cell culture medium containing the mixed solution of three antibodies with different concentrations (penicillin, streptomycin and amphotericin B) to stop digestion when the leech somatic cells shrink but do not float, slightly shaking to remove the culture solution, adding 4mL of PBS (mixed solution of three antibodies with different concentrations (penicillin, streptomycin and amphotericin B) to slightly wash away residual fibroblasts, adding 2mL of digestive juice, digesting for 2-3.5min, removing 1mL of digestive juice, completely beating the cells from the bottom of the bottom flask, adding 5mL of the input-CCulture Insect cell culture medium containing the mixed solution of three antibodies with different concentrations (penicillin, streptomycin and amphotericin B) to stop digestion of the Insect cells, repeatedly blowing and beating the cells to disperse the cell clusters into single cells.
Step ten: and (4) filtering the cells obtained from the ninth step by using eight layers of gauze, inoculating the filtered cells into 25mL culture bottles containing 5mL of Insect-cell culture medium of the infection-CCulture with the three-antibody mixed solution (penicillin, streptomycin and amphotericin B) with different concentrations, culturing at the temperature of 25 ℃ for 3 days, continuing transferring the cells into another 25mL culture bottle containing 5mL of the Insect-cell culture medium of the infection-CCulture, and repeating the previous operation.
The culture medium of the Insect cell of the culture medium Insect-CCulture used by the invention has the following formula:
inorganic salts:
NaCl1420mg/L,ZnCL2 876.54mg/L,MgSO4·7H2O1743.48mg/L,
KCl2080mg/L,KH2PO4·2H2O 1000mg/L;
amino acids:
9000mg/L of DL-serine, 620mg/L of glycine, 700mg/L of L-arginine hydrochloride, 400mg/L of L-asparagine, 350mg/L of L-aspartic acid, 160mg/L of L-cysteine dihydrochloride, 3500mg/L of L-glutamic acid, 2000mg/L of L-histidine hydrochloride, 200mg/L of L-isoleucine, 150mg/L of L-leucine, 850mg/L of L-lysine hydrochloride, 100mg/L of L-methionine, 100mg/L of L-phenylalanine, 500mg/L of L-proline, 200mg/L of L-threonine, 150mg/L of L-tryptophan, 580mg/L of disodium hydrogen phosphate L-tyrosine, l-valine 200mg/L, beta-alanine 400mg/L and L-alanine 225 mg/L;
vitamins:
0.15mg/L of D-biotin, 0.15mg/L of D-calcium pantothenate, 0.15mg/L of folate, 0.10mg/L of cyanocobalamine, 0.15mg/L of nicotinic acid, 0.15mg/L of pyridoxamine hydrochloride, 0.15mg/L of riboflavin, 0.10mg/L of thiamine and 0.15mg/L of p-aminobenzoic acid;
and (3) the other:
2000mg/L of sucrose, 1500mg/L of D-glucose, 500mg/L of D-fructose, 600mg/L of maltose, 330mg/L of alpha-ketoglutaric acid, 90mg/L of fumaric acid, 90mg/L of succinic acid and 90mg/L of L-malic acid;
the pH was adjusted to 7.4 with 1.0N KOH and 15% inactivated insect-specific special grade fetal calf serum was added before use.
This example shows that in the same type of medium, when the penicillin content is 600U/mL, the streptomycin content is 600U/mL, and the amphotericin B content is 15. mu.g/mL, the cell growth condition is the best, and no contamination phenomenon occurs while the cell survival time is long; when the content of penicillin is 200U/mL, the content of streptomycin is 200U/mL and the content of amphotericin B is 5 mug/mL, the turbid phenomenon appears in the culture solution after primary culture for 10 hours, the cells around the tissues are free, and the cells do not grow; when the content of penicillin is 400U/mL, the content of streptomycin is 400U/mL and the content of amphotericin B is 5 mug/mL, the culture solution is light yellow after primary culture for 15 hours, and black granular substances are arranged around tissues, so that no cells are dissociated, and the cells do not grow; when the content of penicillin is 800U/mL, the content of streptomycin is 800U/mL and the content of amphotericin B is 20 mug/mL, the culture solution is clarified after primary culture for 15 hours, no cell is dissociated around the tissue, and the cell does not grow; after 20h of culture, the culture solution is clear, no cells are free around the tissues, and the cells do not grow.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810268999.6A CN108265021B (en) | 2018-03-29 | 2018-03-29 | Leech cell in-vitro culture medium and culture method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810268999.6A CN108265021B (en) | 2018-03-29 | 2018-03-29 | Leech cell in-vitro culture medium and culture method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108265021A CN108265021A (en) | 2018-07-10 |
CN108265021B true CN108265021B (en) | 2021-08-27 |
Family
ID=62777933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810268999.6A Expired - Fee Related CN108265021B (en) | 2018-03-29 | 2018-03-29 | Leech cell in-vitro culture medium and culture method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108265021B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111979174A (en) * | 2020-08-26 | 2020-11-24 | 中国计量大学 | Method for separating hirudo nipponica salivary gland cells |
CN114657120A (en) * | 2022-04-20 | 2022-06-24 | 中国计量大学 | Method for obtaining hirudo nipponica salivary gland stem cell mass through enzymolysis and application |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103045533A (en) * | 2013-01-14 | 2013-04-17 | 华东理工大学 | Serum-free medium suitable for large-scale production of influenza vaccines |
CN105087461A (en) * | 2015-06-18 | 2015-11-25 | 上海源培生物科技股份有限公司 | PK cell culture medium |
CN107129962A (en) * | 2017-05-18 | 2017-09-05 | 中国计量大学 | A kind of primary culture method of Hirudo japonica salivary gland cell |
-
2018
- 2018-03-29 CN CN201810268999.6A patent/CN108265021B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103045533A (en) * | 2013-01-14 | 2013-04-17 | 华东理工大学 | Serum-free medium suitable for large-scale production of influenza vaccines |
CN105087461A (en) * | 2015-06-18 | 2015-11-25 | 上海源培生物科技股份有限公司 | PK cell culture medium |
CN107129962A (en) * | 2017-05-18 | 2017-09-05 | 中国计量大学 | A kind of primary culture method of Hirudo japonica salivary gland cell |
Also Published As
Publication number | Publication date |
---|---|
CN108265021A (en) | 2018-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101491229B (en) | Vitro culturing method of pearl shell mantle tissue and culture medium | |
Vago | Invertebrate tissue culture | |
CN101803581B (en) | A method for cultivating large nucleated pearls | |
CN101491228A (en) | Sea no-nucleus pearl incubation method | |
CN1195844C (en) | Avian primordial germ cell (PGC) cell line and method for long term culturing thereof | |
CN103409365B (en) | Method for establishing schizothorax wangchiachii heart cell line and performing ultralow temperature cryopreservation on schizothorax wangchiachii heart cell line | |
CN108265021B (en) | Leech cell in-vitro culture medium and culture method thereof | |
CN105483075A (en) | Culture medium and method for culturing urechis unicinctus trochophore cell line | |
CN1382806A (en) | Collagen used for deep-sea fish skin tissue engineering and its preparing process | |
CN111808801A (en) | Method for extracting and culturing pigeon skeletal muscle satellite cells | |
CN107129962B (en) | A kind of primary culture method of Hirudo japonica salivary gland cell | |
US4449480A (en) | Culture of freshwater mussel glochidia in an artificial habitat utilizing complex liquid growth media | |
CN115747154B (en) | Culture medium for long-term culture of fish muscle stem cells | |
CN105039241B (en) | Shelled Turtle Trionyx Sinensis heart cell continuous cell line and its construction method and cryopreservation method | |
CN110872573B (en) | Novel method for separating and culturing primary cardiomyocytes of zebra fish | |
CN101423817A (en) | Method for constructing cell line by using insect egg | |
Smyth | Cestoda | |
CN109792972B (en) | In-vitro culture method for cysticercus cellulosae | |
Mellink et al. | In vitro culture of intramolluscan stages of the avian schistosome Trichobilharzia ocellata | |
CN107858322A (en) | A kind of method for building up of hippocampal primary cell culture system | |
Evans | The cultivation of Hymenolepis in vitro | |
CN101423818A (en) | Method for culturing chicken embryonic germ cells and special nutrient fluid thereof | |
Oyama | Neuroendocrine effects on ovarian development in the crab Thalamita crenata Latreille studied in vitro | |
CN103289952A (en) | Cell or tissue culture method | |
CN101591639A (en) | A kind of Hepu pearl oyster tissue culture method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211103 Address after: 215107 No. 1269, Xinzhou highway, Lili Town, Wujiang District, Suzhou City, Jiangsu Province Patentee after: Changzhou Biotechnology (Jiangsu) Co.,Ltd. Address before: 215000 Bamboo Garden Road, Suzhou high tech Zone, Jiangsu Province, No. 209 Patentee before: SUZHOU ZHIHUI BIOTECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210827 |